Anagin Inc logo

Anagin Inc.

Anagin an Indiana based LLC engages in the development of drugs that block the target mechanism of post traumatic stress disorder (PTSD).

Anagin is a product of the Spin Up program created by the Indiana University Research and Technology Corp. and had received various startup grants provided under the program.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://anagin.com
Founded2013
Disease Focus
Development StageTechnology
STOCK CODENon Listed
Address
1800 North Capitol Avenue Indiana Center for Biomedical Innovation Noyes Pavilion 5th Floor Suite E504, IN 46202
Indianapolis
United States
Email
Contact Number
+1 888-526-2446

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/anagin-inc” connections=”true” suffix=””]

Anagin develops drugs that block the target mechanism of PTSD without triggering others that cause crippling side effects such as agitation, irritability, sexual dysfunction, drowsiness, memory lapses, motor skill problems and addiction.

In Feb 2016, Anagin received a one-year SBIR Phase I grant worth $267,381 from the National Institute of Neurological Disorders and Stroke to test the benefits of a compound that could reduce the damage caused by traumatic brain injury. Earlier, Anagin received two NIH SBIR Phase I grant of $692,706 to develop drug against post traumatic stress disorder (PTSD).